Healthcare companies in the neurovascular embolization devices (neurology) market have successfully established a strong foundation for treatment options with the help of embolization coils and liquid embolic systems. However, these treatment options present unique challenges in certain health conditions such as wide-neck bifurcated aneurysms. To overcome this challenge, manufacturers are introducing single-treatment saccular implants. Based on the same principle, healthcare companies in the neurovascular embolization devices (neurology) market are developing Woven EndoBridge (WEB) aneurysm embolization systems that overcome the complications associated with coil-assist devices and surgical clippings.
WEB devices are gaining prominence as a less-invasive treatment alternative for wide-neck intracranial aneurysms in the neurovascular embolization devices (neurology) market space. This is why, many healthcare companies are investing in WEB devices and seeking the approval of health commissions. For instance, in January 2019, MicroVention — a neuroendovascular medical device company, announced the launch of an FDA-approved WEB aneurysm embolization system for the treatment of wide-neck bifurcated aneurysms.
Get a glimpse of the in-depth analysis through our Report Brochure
Recent advances in device technology are more focused on the control and precision of device placement during deployment procedures. To achieve this, healthcare companies in the neurovascular embolization devices (neurology) market are innovating in flow diversion technology. This is evident, as among the products in the neurovascular embolization devices (neurology) market, flow diversion stents are estimated to have the second-highest revenue of ~US$ 215 million by 2027.
Flow diversion technology has triggered the need for improved devices in the neurovascular embolization devices (neurology) landscape. As such, manufacturers are increasing the availability of flow-diverting devices for use in hospitals and ambulatory surgical centers. However, flow-diverting devices lead to challenging complications such as vertebrobasilar aneurysms in patients. Thus, healthcare companies are overcoming this limitation by seeking licensed approval from health commissions, so that their devices are credible. They are increasing research & development to validate clinically-approved data on the long-term benefits of using flow-diverting devices.
To know the scope of our report Get a Sample on Neurovascular Embolization Devices (Neurology) Market
Although flow diversion stents result in fewer complications in patients, lack of clinical evidence about their long-term outcome remains a matter of debate. This is why, healthcare companies in the neurovascular embolization devices (neurology) market are supporting the treatment infrastructure with pipeline embolization devices (PEDs). Since these devices are outperforming other endoluminal devices, manufacturers are promoting their application for bifurcation aneurysms.
Posterior circulation aneurysm is another driver that is demanding the need for PEDs in the neurovascular embolization devices (neurology) market. As such, manufacturers are introducing variations in braided stents, local porosity, and filament position modeled with cone beam computed tomography to provide critical information to healthcare providers, prior to surgical treatments. PED technology is being rapidly transformed into pipeline flex technology. Although limited studies prove its long-term outcomes, pipeline flex is found to be a safe treatment option, and it serves as a short-term efficacy alternative.
Expanding operations in future? To get the perfect launch ask for a custom report
Analysts’ Viewpoint
The adoption of WEB devices for neurovascular embolization treatment is relatively slow in European countries. Thus, manufacturers in the neurovascular embolization devices (neurology) market should increase production capabilities for WEB devices in North America, since this region is projected to account for the largest market share in the neurovascular embolization devices (neurology) market over the forecast period.
Although embolization coils and flow diversion stents account for a significant amount of the revenue in the market, health complications associated with these products act as a hurdle for manufacturers. Taking a cue from the North America market, manufacturers in Europe and Asia Pacific should develop and promote WEB devices that will help create more incremental opportunities in these high-growth regions.
To gain credibility in the market, healthcare companies should seek approvals, such as the FDA Premarket Approval (PMA), to strategically market their product offerings in the highly consolidated global neurovascular embolization devices (neurology) market.
Neurovascular Embolization Devices (Neurology) Market: Overview
Neurovascular Embolization Devices (Neurology) Market: Segment Analysis
Neurovascular Embolization Devices (Neurology) Market: Key Insights
Neurovascular Embolization Devices (Neurology) Market: Prominent Players
Neurovascular Embolization Devices (Neurology) Market – Segmentation
|
Product |
|
|
Treatment |
|
|
Indication |
|
|
End User |
|
|
Region |
|
Neurovascular embolization devices (neurology) market is anticipated to reach ~US$ 1.6 Bn by 2027
Neurovascular embolization devices (neurology) market to expand at a CAGR of ~3% from 2019 to 2027
Neurovascular embolization devices (neurology) market is driven by increase in incidence of neurovascular diseases across the globe
The embolization coils product segment dominated the global neurovascular embolization devices (neurology) market
Key players in the global neurovascular embolization devices (neurology) market include Stryker Corporation, Terumo Medical Corporation, DePuy Synthes (Johnson & Johnson Services, Inc.), Boston Scientific Corporation, Acandis GmbH
1. Preface
1.1. Market Definition and Scope
1.2. Market Segmentation
1.3. Key Research Objectives
1.4. Research Highlights
2. Assumptions and Research Methodology
3. Executive Summary : Global Neurovascular Embolization Devices (Neurology) Market
4. Market Overview
4.1. Introduction
4.2. Overview
4.3. Market Dynamics
4.3.1. Drivers
4.3.2. Restraints
4.3.3. Opportunities
4.4. Global Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast, 2017–2027
4.4.1. Market Revenue Projections (US$ Mn)
5. Market Outlook
5.1. Key Industry Developments
5.2. Regulatory Scenario
5.3. Reimbursement Scenario
5.4. Key Mergers & Acquisitions
5.5. Technological Advancements
6. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product
6.1. Introduction & Definition
6.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
6.2.1. Embolization Coils
6.2.2. Liquid Embolic Systems
6.2.3. Flow Diversion Stents
6.2.4. Aneurysm Clips
6.2.5. Others
6.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product
7. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment
7.1. Introduction & Definition
7.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
7.2.1. Ischemic Stroke Solution
7.2.2. Hemorrhagic Stroke Solution
7.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment
8. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication
8.1. Introduction
8.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
8.2.1. Brain Aneurysms
8.2.2. Arteriovenous Malformation (AVM)
8.2.3. Others
8.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication
9. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User
9.1. Introduction
9.2. Global Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
9.2.1. Hospitals
9.2.2. Ambulatory Surgery Centers
9.2.3. Specialty Clinics
9.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User
10. Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region
10.1. Introduction
10.2. Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Region, 2017–2027
10.2.1. North America
10.2.2. Europe
10.2.3. Asia Pacific
10.2.4. Latin America
10.2.5. Middle East & Africa
10.3. Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Region
11. North America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
11.1. Introduction
11.2. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
11.2.1. Embolization Coils
11.2.2. Liquid Embolic Systems
11.2.3. Flow Diversion Stents
11.2.4. Aneurysm Clips
11.2.5. Others
11.3. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
11.3.1. Ischemic Stroke Solution
11.3.2. Hemorrhagic Stroke Solution
11.4. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
11.4.1. Brain Aneurysms
11.4.2. Arteriovenous Malformation (AVM)
11.4.3. Others
11.5. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
11.5.1. Hospitals
11.5.2. Ambulatory Surgery Centers
11.5.3. Specialty Clinics
11.6. North America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
11.6.1. U.S.
11.6.2. Canada
11.7. North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
11.7.1. By Product
11.7.2. By Treatment
11.7.3. By Indication
11.7.4. By End User
11.7.5. By Country/Sub-region
12. Europe Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
12.1. Introduction
12.2. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
12.2.1. Embolization Coils
12.2.2. Liquid Embolic Systems
12.2.3. Flow Diversion Stents
12.2.4. Aneurysm Clips
12.2.5. Others
12.3. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
12.3.1. Ischemic Stroke Solution
12.3.2. Hemorrhagic Stroke Solution
12.4. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
12.4.1. Brain Aneurysms
12.4.2. Arteriovenous Malformation (AVM)
12.4.3. Others
12.5. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
12.5.1. Hospitals
12.5.2. Ambulatory Surgery Centers
12.5.3. Specialty Clinics
12.6. Europe Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
12.6.1. Germany
12.6.2. U.K.
12.6.3. France
12.6.4. Spain
12.6.5. Italy
12.6.6. Rest of Europe
12.7. Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
12.7.1. By Product
12.7.2. By Treatment
12.7.3. By Indication
12.7.4. By End User
12.7.5. By Country/Sub-region
13. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
13.1. Introduction
13.2. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
13.2.1. Embolization Coils
13.2.2. Liquid Embolic Systems
13.2.3. Flow Diversion Stents
13.2.4. Aneurysm Clips
13.2.5. Others
13.3. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
13.3.1. Ischemic Stroke Solution
13.3.2. Hemorrhagic Stroke Solution
13.4. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
13.4.1. Brain Aneurysms
13.4.2. Arteriovenous Malformation (AVM)
13.4.3. Others
13.5. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
13.5.1. Hospitals
13.5.2. Ambulatory Surgery Centers
13.5.3. Specialty Clinics
13.6. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
13.6.1. Japan
13.6.2. China
13.6.3. India
13.6.4. Australia & New Zealand
13.6.5. Rest of Asia Pacific
13.7. Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
13.7.1. By Product
13.7.2. By Treatment
13.7.3. By Indication
13.7.4. By End User
13.7.5. By Country/Sub-region
14. Latin America Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
14.1. Introduction
14.2. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
14.2.1. Embolization Coils
14.2.2. Liquid Embolic Systems
14.2.3. Flow Diversion Stents
14.2.4. Aneurysm Clips
14.2.5. Others
14.3. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
14.3.1. Ischemic Stroke Solution
14.3.2. Hemorrhagic Stroke Solution
14.4. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
14.4.1. Brain Aneurysms
14.4.2. Arteriovenous Malformation (AVM)
14.4.3. Others
14.5. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
14.5.1. Hospitals
14.5.2. Ambulatory Surgery Centers
14.5.3. Specialty Clinics
14.6. Latin America Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
14.6.1. Brazil
14.6.2. Mexico
14.6.3. Rest of Latin America
14.7. Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
14.7.1. By Product
14.7.2. By Treatment
14.7.3. By Indication
14.7.4. By End User
14.7.5. By Country/Sub-region
15. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Analysis and Forecast
15.1. Introduction
15.2. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Product, 2017–2027
15.2.1. Embolization Coils
15.2.2. Liquid Embolic Systems
15.2.3. Flow Diversion Stents
15.2.4. Aneurysm Clips
15.2.5. Others
15.3. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Treatment, 2017–2027
15.3.1. Ischemic Stroke Solution
15.3.2. Hemorrhagic Stroke Solution
15.4. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Indication, 2017–2027
15.4.1. Brain Aneurysms
15.4.2. Arteriovenous Malformation (AVM)
15.4.3. Others
15.5. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by End User, 2017–2027
15.5.1. Hospitals
15.5.2. Ambulatory Surgery Centers
15.5.3. Specialty Clinics
15.6. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Forecast, by Country/Sub-region, 2017–2027
15.6.1. GCC Countries
15.6.2. South Africa
15.6.3. Rest of Middle East & Africa
15.7. Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis
15.7.1. By Product
15.7.2. By Treatment
15.7.3. By Indication
15.7.4. By End User
15.7.5. By Country/Sub-region
16. Competition Landscape
16.1. Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
16.2. Company Profiles
16.2.1. Medtronic plc
16.2.1.1. Company Description
16.2.1.2. Business Overview
16.2.1.3. Financial Overview
16.2.1.4. Strategic Overview
16.2.1.5. SWOT Analysis
16.2.2. Stryker Corporation
16.2.2.1. Company Description
16.2.2.2. Business Overview
16.2.2.3. Financial Overview
16.2.2.4. Strategic Overview
16.2.2.5. SWOT Analysis
16.2.3. DePuy Synthes (Johnson & Johnson Services, Inc.)
16.2.3.1. Company Description
16.2.3.2. Business Overview
16.2.3.3. Financial Overview
16.2.3.4. Strategic Overview
16.2.3.5. SWOT Analysis
16.2.4. B.Braun Melsungen AG
16.2.4.1. Company Description
16.2.4.2. Business Overview
16.2.4.3. Financial Overview
16.2.4.4. Strategic Overview
16.2.4.5. SWOT Analysis
16.2.5. Penumbra, Inc.
16.2.5.1. Company Description
16.2.5.2. Business Overview
16.2.5.3. Financial Overview
16.2.5.4. Strategic Overview
16.2.5.5. SWOT Analysis
16.2.6. Acandis GmbH
16.2.6.1. Company Description
16.2.6.2. Business Overview
16.2.6.3. Financial Overview
16.2.6.4. Strategic Overview
16.2.6.5. SWOT Analysis
16.2.7. BALT EXTRUSION
16.2.7.1. Company Description
16.2.7.2. Business Overview
16.2.7.3. Financial Overview
16.2.7.4. Strategic Overview
16.2.7.5. SWOT Analysis
16.2.8. Terumo Medical Corporation
16.2.8.1. Company Description
16.2.8.2. Business Overview
16.2.8.3. Financial Overview
16.2.8.4. Strategic Overview
16.2.8.5. SWOT Analysis
16.2.9. Boston Scientific Corporation
16.2.9.1. Company Description
16.2.9.2. Business Overview
16.2.9.3. Financial Overview
16.2.9.4. Strategic Overview
16.2.9.5. SWOT Analysis
16.2.10. Spartan Micro, Inc.
16.2.10.1. Company Description
16.2.10.2. Business Overview
16.2.10.3. Financial Overview
16.2.10.4. Strategic Overview
16.2.10.5. SWOT Analysis
List of Tables
Table 01: Hospital Inpatient Billing and Payment Reimbursement Scenario
Table 02: Physician Billing and Payment for Reimbursement
Table 03: Key Mergers and Acquisitions
Table 04: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 05: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017–2027
Table 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017–2027
Table 07: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017–2027
Table 08: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Region, 2017–2027
Table 09: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country, 2017–2027
Table 10: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 11: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
Table 12: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
Table 13: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 14: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 15: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 16: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
Table 17: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
Table 18: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 19: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 20: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 21: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
Table 22: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
Table 23: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 24: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 25: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 26: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
Table 27: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
Table 28: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
Table 29: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Country/Sub-region, 2017–2027
Table 30: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Product, 2017–2027
Table 31: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Treatment, 2017?2027
Table 32: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by Indication, 2017?2027
Table 33: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, by End User, 2017?2027
List of Figures
Figure 01: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Distribution (%), by Region, 2019 and 2027
Figure 02: Neurovascular Embolization Devices (Neurology) Market – Key Industry Developments
Figure 03: Market Drivers
Figure 04: Market Restraints
Figure 05: Key Opportunities
Figure 06: Global Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast, 2017–2027
Figure 07: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product (2018)
Figure 08: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment (2018)
Figure 09: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication (2018)
Figure 10: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User (2018)
Figure 11: Europe Regulatory Approval Process
Figure 12: Technological Advancements
Figure 13: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 14: Global Neurovascular Embolization Devices Neurology) Market Attractiveness, by Product, 2019–2027
Figure 15: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Embolization Coils, 2017–2027
Figure 16: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Liquid Embolic Systems, 2017–2027
Figure 17: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Flow Diversion Stents, 2017–2027
Figure 18: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Aneurysm Clips, 2017–2027
Figure 19: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 20: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 21: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 22: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hemorrhagic Stroke Solution, 2017–2027
Figure 23: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ischemic Stroke Solution, 2017–2027
Figure 24: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 25: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 26: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Brain Aneurysms, 2017–2027
Figure 27: Global Ne Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Arteriovenous Malformations (AVMs), 2017–2027
Figure 28: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Others, 2017–2027
Figure 29: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 30: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 31: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Hospitals, 2017–2027
Figure 32: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Ambulatory Surgical Centers, 2017–2027
Figure 33: Global Neurovascular Embolization Devices (Neurology) Market Revenue (US$ Mn) and Y-o-Y Growth (%), by Specialty Clinics, 2017–2027
Figure 34: Global Neurovascular Embolization Devices (Neurology) Market: Regional Outlook
Figure 35: Global Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Region, 2018 and 2027
Figure 36: Global Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Region, 2019–2027
Figure 37: North America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 38: North America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country, 2018 and 2027
Figure 39: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country, 2019–2027
Figure 40: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 41: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027
Figure 42: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 43: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 44: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 45: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 46: North America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 47: North America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 48: Europe Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 49: Europe Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 50: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 51: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 52: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027
Figure 53: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 54: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 55: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 56: Europe N Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 57: Europe Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 58: Europe Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 59: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 60: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 61: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 62: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 63: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027
Figure 64: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 65: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 66: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 67: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 68: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 69: Asia Pacific Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 70: Latin America Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 71: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 72: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 73: Latin Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 74: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027
Figure 75: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 76: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 77: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 78: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 79: Latin America Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 80: Latin America Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 81: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value (US$ Mn) Forecast and Y-o-Y Growth (%) Projection, 2017–2027
Figure 82: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share Analysis, by Country/Sub-region, 2018 and 2027
Figure 83: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness Analysis, by Country/Sub-region, 2019–2027
Figure 84: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Product, 2018 and 2027
Figure 85: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Product, 2019–2027
Figure 86: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Treatment, 2018 and 2027
Figure 87: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Treatment, 2019–2027
Figure 88: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by Indication, 2018 and 2027
Figure 89: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by Indication, 2019–2027
Figure 90: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Value Share (%), by End User, 2018 and 2027
Figure 91: Middle East & Africa Neurovascular Embolization Devices (Neurology) Market Attractiveness, by End User, 2019–2027
Figure 92: Global Neurovascular Embolization Devices (Neurology) Market Share Analysis, by Company (2018)
Copyright © Transparency Market Research, Inc. All Rights reserved
Trust Online
Neurovascular Embolization Devices (Neurology) Market
